Impaired glucose homeostasis and a novel HLCS pathogenic variant in holocarboxylase synthetase deficiency: a report of two cases and brief review.

Abstract

Objectives Holocarboxylase synthetase deficiency (HCSD) (OMIM #253270) is a rare inborn error of metabolism with an estimated annual incidence of 1 in 200,000 people. Typical manifestations of HCSD include eczema, alopecia, lactic acidosis and hyperammonemia. Diagnosis is made through genetic analysis. Case presentation Patient 1 was a 7-year-old girl with normal growth and development, presenting with severe hypoglycemia and metabolic acidosis. Her family reported that she was diagnosed as having ketotic hypoglycemia; she had five episodes of hypoglycemia and metabolic acidosis in past 4 years when her oral intake decreased during acute illness. Patient 2 was a 6-month-old female infant with normal growth and development, presenting with progressive generalized eczema and metabolic acidosis for the first time. We found that they both had hyperammonemia, hyperlactatemia, hyperketonemia, organic acids detected in urine and elevated C5OH acylcarnitine level by tandem mass spectrometry. HLCS gene analysis showed a homozygous pathogenic variant p.V363D in patient 1 and a pathogenic variant p.R508W compound with a novel splice site pathogenic variant c.2010-1G>A in patient 2. They have been on biotin treatment (10 mg/day for both of them) for more than 2 years and no more symptoms have occurred. Conclusions HCSD is a rare disease, and it can be fatal if severe metabolic acidosis occurs without timely management. Once the diagnosis is made, most of the patients with HCSD have good prognosis and normal life expectancy with biotin treatment.

• Authors: Hsin-Ru Wu, Kuan-Jung Chen, Hui-Pin Hsiao, Mei-Chyn Chao
• Journal: Journal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 33 Issue 11 Pg. 1481-1486 (Nov 26 2020) ISSN: 2191-0251 [Electronic] Germany
• PMID: 32841162 (Publication Type: Case Reports, Journal Article, Review)

Chemical References

• Biotin
• Carbon-Nitrogen Ligases
• holocarboxylase synthetases
• Glucose

Topics

• Acidosis (diagnosis, drug therapy, genetics, metabolism)
• Biotin (therapeutic use)
• Carbon-Nitrogen Ligases (genetics)
• Child
• Female
• Glucose (metabolism)
• Holocarboxylase Synthetase Deficiency (complications, diagnosis, drug therapy, genetics)
• Homeostasis
• Humans
• Hypoglycemia (diagnosis, drug therapy, genetics, metabolism)
• Infant
• Mutation, Missense
• Prognosis
• Taiwan